Researchers find a promising new approach for treating liver cirrhosis
Aleglitazar improves portal hypertension in rats with cirrhosis by suppressing…
Aleglitazar improves portal hypertension in rats with cirrhosis by suppressing inflammation, vasoconstriction, and angiogenesis...